The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Osteoarthritis Pain-Global Market Insights and Sales Trends 2025
Synopsis
Osteoarthritis, the most common type of arthritis, is a leading cause of disability.
The global Osteoarthritis Pain market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Osteoarthritis Pain in various end use industries. The expanding demands from the Hospital, Pharmacy and Other, are propelling Osteoarthritis Pain market. Oral, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Non-Oral segment is estimated at % CAGR for the next seven-year period.
It is also known as degenerative joint disease, hypertrophic arthritis, and degenerative arthritis, and is most commonly prevalent in older (above 60 years of age) and middle-aged people (between 40-59 years of age).
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Osteoarthritis Pain, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Osteoarthritis Pain market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Osteoarthritis Pain market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Osteoarthritis Pain sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Osteoarthritis Pain covered in this report include Abbott Laboratories, Johnson & Johnson, Novartis International, Pfizer, AbbVie, Abiogen Pharma, Afferent Pharmaceuticals, Astellas Pharma and BioDelivery Sciences International, etc.
The global Osteoarthritis Pain market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Abbott Laboratories
Johnson & Johnson
Novartis International
Pfizer
AbbVie
Abiogen Pharma
Afferent Pharmaceuticals
Astellas Pharma
BioDelivery Sciences International
Crystal Genomics
Cytori Therapeutics
Global Osteoarthritis Pain market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Osteoarthritis Pain market, Segment by Type:
Oral
Non-Oral
Global Osteoarthritis Pain market, by Application
Hospital
Pharmacy
Other
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Osteoarthritis Pain manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Osteoarthritis Pain in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Osteoarthritis, the most common type of arthritis, is a leading cause of disability.
The global Osteoarthritis Pain market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Osteoarthritis Pain in various end use industries. The expanding demands from the Hospital, Pharmacy and Other, are propelling Osteoarthritis Pain market. Oral, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Non-Oral segment is estimated at % CAGR for the next seven-year period.
It is also known as degenerative joint disease, hypertrophic arthritis, and degenerative arthritis, and is most commonly prevalent in older (above 60 years of age) and middle-aged people (between 40-59 years of age).
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Osteoarthritis Pain, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Osteoarthritis Pain market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Osteoarthritis Pain market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Osteoarthritis Pain sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Osteoarthritis Pain covered in this report include Abbott Laboratories, Johnson & Johnson, Novartis International, Pfizer, AbbVie, Abiogen Pharma, Afferent Pharmaceuticals, Astellas Pharma and BioDelivery Sciences International, etc.
The global Osteoarthritis Pain market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Abbott Laboratories
Johnson & Johnson
Novartis International
Pfizer
AbbVie
Abiogen Pharma
Afferent Pharmaceuticals
Astellas Pharma
BioDelivery Sciences International
Crystal Genomics
Cytori Therapeutics
Global Osteoarthritis Pain market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Osteoarthritis Pain market, Segment by Type:
Oral
Non-Oral
Global Osteoarthritis Pain market, by Application
Hospital
Pharmacy
Other
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Osteoarthritis Pain manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Osteoarthritis Pain in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index1 Osteoarthritis Pain Market Overview
1.1 Osteoarthritis Pain Product Overview
1.2 Osteoarthritis Pain Market Segment by Type
1.2.1 Oral
1.2.2 Non-Oral
1.3 Global Osteoarthritis Pain Market Size by Type
1.3.1 Global Osteoarthritis Pain Market Size Overview by Type (2018-2029)
1.3.2 Global Osteoarthritis Pain Historic Market Size Review by Type (2018-2023)
1.3.3 Global Osteoarthritis Pain Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Osteoarthritis Pain Sales Breakdown by Type (2018-2023)
1.4.2 Europe Osteoarthritis Pain Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Osteoarthritis Pain Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Osteoarthritis Pain Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Osteoarthritis Pain Sales Breakdown by Type (2018-2023)
2 Global Osteoarthritis Pain Market Competition by Company
2.1 Global Top Players by Osteoarthritis Pain Sales (2018-2023)
2.2 Global Top Players by Osteoarthritis Pain Revenue (2018-2023)
2.3 Global Top Players by Osteoarthritis Pain Price (2018-2023)
2.4 Global Top Manufacturers Osteoarthritis Pain Manufacturing Base Distribution, Sales Area, Product Type
2.5 Osteoarthritis Pain Market Competitive Situation and Trends
2.5.1 Osteoarthritis Pain Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Osteoarthritis Pain Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Osteoarthritis Pain as of 2022)
2.7 Date of Key Manufacturers Enter into Osteoarthritis Pain Market
2.8 Key Manufacturers Osteoarthritis Pain Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Osteoarthritis Pain Status and Outlook by Region
3.1 Global Osteoarthritis Pain Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Osteoarthritis Pain Historic Market Size by Region
3.2.1 Global Osteoarthritis Pain Sales in Volume by Region (2018-2023)
3.2.2 Global Osteoarthritis Pain Sales in Value by Region (2018-2023)
3.2.3 Global Osteoarthritis Pain Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Osteoarthritis Pain Forecasted Market Size by Region
3.3.1 Global Osteoarthritis Pain Sales in Volume by Region (2024-2029)
3.3.2 Global Osteoarthritis Pain Sales in Value by Region (2024-2029)
3.3.3 Global Osteoarthritis Pain Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Osteoarthritis Pain by Application
4.1 Osteoarthritis Pain Market Segment by Application
4.1.1 Hospital
4.1.2 Pharmacy
4.1.3 Other
4.2 Global Osteoarthritis Pain Market Size by Application
4.2.1 Global Osteoarthritis Pain Market Size Overview by Application (2018-2029)
4.2.2 Global Osteoarthritis Pain Historic Market Size Review by Application (2018-2023)
4.2.3 Global Osteoarthritis Pain Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Osteoarthritis Pain Sales Breakdown by Application (2018-2023)
4.3.2 Europe Osteoarthritis Pain Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Osteoarthritis Pain Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Osteoarthritis Pain Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Osteoarthritis Pain Sales Breakdown by Application (2018-2023)
5 North America Osteoarthritis Pain by Country
5.1 North America Osteoarthritis Pain Historic Market Size by Country
5.1.1 North America Osteoarthritis Pain Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Osteoarthritis Pain Sales in Volume by Country (2018-2023)
5.1.3 North America Osteoarthritis Pain Sales in Value by Country (2018-2023)
5.2 North America Osteoarthritis Pain Forecasted Market Size by Country
5.2.1 North America Osteoarthritis Pain Sales in Volume by Country (2024-2029)
5.2.2 North America Osteoarthritis Pain Sales in Value by Country (2024-2029)
6 Europe Osteoarthritis Pain by Country
6.1 Europe Osteoarthritis Pain Historic Market Size by Country
6.1.1 Europe Osteoarthritis Pain Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Osteoarthritis Pain Sales in Volume by Country (2018-2023)
6.1.3 Europe Osteoarthritis Pain Sales in Value by Country (2018-2023)
6.2 Europe Osteoarthritis Pain Forecasted Market Size by Country
6.2.1 Europe Osteoarthritis Pain Sales in Volume by Country (2024-2029)
6.2.2 Europe Osteoarthritis Pain Sales in Value by Country (2024-2029)
7 Asia-Pacific Osteoarthritis Pain by Region
7.1 Asia-Pacific Osteoarthritis Pain Historic Market Size by Region
7.1.1 Asia-Pacific Osteoarthritis Pain Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Osteoarthritis Pain Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Osteoarthritis Pain Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Osteoarthritis Pain Forecasted Market Size by Region
7.2.1 Asia-Pacific Osteoarthritis Pain Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Osteoarthritis Pain Sales in Value by Region (2024-2029)
8 Latin America Osteoarthritis Pain by Country
8.1 Latin America Osteoarthritis Pain Historic Market Size by Country
8.1.1 Latin America Osteoarthritis Pain Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Osteoarthritis Pain Sales in Volume by Country (2018-2023)
8.1.3 Latin America Osteoarthritis Pain Sales in Value by Country (2018-2023)
8.2 Latin America Osteoarthritis Pain Forecasted Market Size by Country
8.2.1 Latin America Osteoarthritis Pain Sales in Volume by Country (2024-2029)
8.2.2 Latin America Osteoarthritis Pain Sales in Value by Country (2024-2029)
9 Middle East and Africa Osteoarthritis Pain by Country
9.1 Middle East and Africa Osteoarthritis Pain Historic Market Size by Country
9.1.1 Middle East and Africa Osteoarthritis Pain Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Osteoarthritis Pain Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Osteoarthritis Pain Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Osteoarthritis Pain Forecasted Market Size by Country
9.2.1 Middle East and Africa Osteoarthritis Pain Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Osteoarthritis Pain Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Abbott Laboratories
10.1.1 Abbott Laboratories Company Information
10.1.2 Abbott Laboratories Introduction and Business Overview
10.1.3 Abbott Laboratories Osteoarthritis Pain Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Abbott Laboratories Osteoarthritis Pain Products Offered
10.1.5 Abbott Laboratories Recent Development
10.2 Johnson & Johnson
10.2.1 Johnson & Johnson Company Information
10.2.2 Johnson & Johnson Introduction and Business Overview
10.2.3 Johnson & Johnson Osteoarthritis Pain Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Johnson & Johnson Osteoarthritis Pain Products Offered
10.2.5 Johnson & Johnson Recent Development
10.3 Novartis International
10.3.1 Novartis International Company Information
10.3.2 Novartis International Introduction and Business Overview
10.3.3 Novartis International Osteoarthritis Pain Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Novartis International Osteoarthritis Pain Products Offered
10.3.5 Novartis International Recent Development
10.4 Pfizer
10.4.1 Pfizer Company Information
10.4.2 Pfizer Introduction and Business Overview
10.4.3 Pfizer Osteoarthritis Pain Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Pfizer Osteoarthritis Pain Products Offered
10.4.5 Pfizer Recent Development
10.5 AbbVie
10.5.1 AbbVie Company Information
10.5.2 AbbVie Introduction and Business Overview
10.5.3 AbbVie Osteoarthritis Pain Sales, Revenue and Gross Margin (2018-2023)
10.5.4 AbbVie Osteoarthritis Pain Products Offered
10.5.5 AbbVie Recent Development
10.6 Abiogen Pharma
10.6.1 Abiogen Pharma Company Information
10.6.2 Abiogen Pharma Introduction and Business Overview
10.6.3 Abiogen Pharma Osteoarthritis Pain Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Abiogen Pharma Osteoarthritis Pain Products Offered
10.6.5 Abiogen Pharma Recent Development
10.7 Afferent Pharmaceuticals
10.7.1 Afferent Pharmaceuticals Company Information
10.7.2 Afferent Pharmaceuticals Introduction and Business Overview
10.7.3 Afferent Pharmaceuticals Osteoarthritis Pain Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Afferent Pharmaceuticals Osteoarthritis Pain Products Offered
10.7.5 Afferent Pharmaceuticals Recent Development
10.8 Astellas Pharma
10.8.1 Astellas Pharma Company Information
10.8.2 Astellas Pharma Introduction and Business Overview
10.8.3 Astellas Pharma Osteoarthritis Pain Sales, Revenue and Gross Margin (2018-2023)
10.8.4 Astellas Pharma Osteoarthritis Pain Products Offered
10.8.5 Astellas Pharma Recent Development
10.9 BioDelivery Sciences International
10.9.1 BioDelivery Sciences International Company Information
10.9.2 BioDelivery Sciences International Introduction and Business Overview
10.9.3 BioDelivery Sciences International Osteoarthritis Pain Sales, Revenue and Gross Margin (2018-2023)
10.9.4 BioDelivery Sciences International Osteoarthritis Pain Products Offered
10.9.5 BioDelivery Sciences International Recent Development
10.10 Crystal Genomics
10.10.1 Crystal Genomics Company Information
10.10.2 Crystal Genomics Introduction and Business Overview
10.10.3 Crystal Genomics Osteoarthritis Pain Sales, Revenue and Gross Margin (2018-2023)
10.10.4 Crystal Genomics Osteoarthritis Pain Products Offered
10.10.5 Crystal Genomics Recent Development
10.11 Cytori Therapeutics
10.11.1 Cytori Therapeutics Company Information
10.11.2 Cytori Therapeutics Introduction and Business Overview
10.11.3 Cytori Therapeutics Osteoarthritis Pain Sales, Revenue and Gross Margin (2018-2023)
10.11.4 Cytori Therapeutics Osteoarthritis Pain Products Offered
10.11.5 Cytori Therapeutics Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Osteoarthritis Pain Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Osteoarthritis Pain Industrial Chain Analysis
11.4 Osteoarthritis Pain Market Dynamics
11.4.1 Osteoarthritis Pain Industry Trends
11.4.2 Osteoarthritis Pain Market Drivers
11.4.3 Osteoarthritis Pain Market Challenges
11.4.4 Osteoarthritis Pain Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Osteoarthritis Pain Distributors
12.3 Osteoarthritis Pain Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
